Production assessment of 195mPt in Tehran research reactor-Reference-Cited by-同舟云学术

Production assessment of 195mPt in Tehran research reactor

Published:2023-07-06 Issue:8 Volume:332 Page:2989-2994
ISSN:0236-5731
Container-title:Journal of Radioanalytical and Nuclear Chemistry
language:en
Short-container-title:J Radioanal Nucl Chem

Author:

Vosoughi Sara,Rovias Mohammad Reza Aboudzadeh,Rahiminezhad Ali,Novin Fatemeh Bolouri,Yousefi Kamran,Sardjono Yohannes

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10967-023-09008-x.pdf

Reference18 articles.

1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, & Bray F (2020) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available online: https://gco.iarc.fr/today

2. Aalbersberg E A (2019) Imaging biomarker development and optimization of 195mPt-cisplatin and 68Ga-DOTATATE. Doctoral dissertation, Utrecht University

3. Ku A, Facca VJ, Cai Z, Reilly RM (2019) Auger electrons for cancer therapy–a review. EJNMMI Radiopharm Chem 4(1):1–36

4. Jackson H, McAuliffe CA, Perera A, Sharma HL, Tinker NJ (1991) An improved synthetic procedure for the preparation of 195mPt labelled anti-tumour complexes. J Label Compd Radiopharm 29(10):1121–1130

5. Zeevaart JR, Wagener J, Marjanovic-Painter B, Sathekge M, Soni N, Zinn C, Smith SV (2013) Production of high specific activity 195mPt-cisplatinum at South African nuclear energy corporation for phase 0 clinical trials in healthy individual subjects. J Label Compd Radiopharm 56(4):95–503